University of South Florida Asthma Allergy and Immunology Clinical Research Unit — Tampa, Florida

University of South Florida Asthma Allergy and Immunology Clinical Research Unit is a clinical research site located in Tampa, Florida, United States 33613.

Crixeo Health Trust Score: 57/100 (POOR). This profile has not yet been claimed by the site owner.

University of South Florida Asthma Allergy and Immunology Clinical Research Unit has participated in 1 clinical trials.

Therapeutic areas: SARS-CoV Infection, COVID-19, Allergic Reaction.

Sponsors: National Institute of Allergy and Infectious Diseases (NIAID).

Sponsor Feasibility Report

Trust Score: 57/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of South Florida Asthma Allergy and Immunology Clinical Research Unit?

University of South Florida Asthma Allergy and Immunology Clinical Research Unit has a Crixeo Trust Score of 57/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of South Florida Asthma Allergy and Immunology Clinical Research Unit conducted?

University of South Florida Asthma Allergy and Immunology Clinical Research Unit has 1 clinical trials on record. Their work covers SARS-CoV Infection, COVID-19, Allergic Reaction.

Is University of South Florida Asthma Allergy and Immunology Clinical Research Unit accredited by Crixeo Health?

University of South Florida Asthma Allergy and Immunology Clinical Research Unit has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about University of South Florida Asthma Allergy and Immunology Clinical Research Unit?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.